Genmab A (GMAB) Shares Outstanding (2018 - 2026)

Genmab A (GMAB) posted Shares Outstanding (Entity) of $64.7 million for Q4 2025, up 130.56% on a QoQ basis from $28.1 million in Q3 2020.

Genmab A (GMAB) Shares Outstanding (2018 - 2026) Analysis & Trends

Genmab A's Shares Outstanding (Entity) history runs 2 years deep, the most recent figure standing at $64.7 million for Q4 2025.

Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $64.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $64.7 million (changed N/A YoY) and the FY2025 annual result came in at $64.7 million, changed N/A from the prior year.
Shares Outstanding (Entity) was $64.7 million for Q4 2025 at Genmab A, up from $28.1 million in the prior quarter.
Across five years, Shares Outstanding (Entity) topped out at $64.7 million in Q4 2025 and bottomed at $64.7 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	6,012.74 Bn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	47.82 Bn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	1.44 Bn
4	NuCana	279.75 Bn	279.75 Bn	-	11.23 Bn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	254.10 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	400.00 Mn
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	62.19 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	198.10 Mn
10	Genmab A	1.89 Bn	366.92 Mn	831.00 Mn	64.72 Mn

Download Data